A phenotype-genotype approach to predicting CYP450 and P-glycoprotein drug interactions with the mixed inhibitor/inducer tipranavir/ritonavir
Dumond, J B, Vourvahis, M, Rezk, N L, Patterson, K B, Tien, H-C, White, N, Jennings, S H, Choi, S O, Li, J, Wagner, M J, La-Beck, N M, Drulak, M, Sabo, J P, Castles, M A, Macgregor, T R, Kashuba, A D M
Published in Clinical pharmacology and therapeutics (01.06.2010)
Published in Clinical pharmacology and therapeutics (01.06.2010)
Get more information
Journal Article
Cellular function of the mononuclear phagocyte system (MPS) as a phenotypic probe for pegylated liposomal doxorubicin (PLD) pharmacokinetics (PK) in patients with recurrent ovarian cancer
Caron, W. P., Lay, J. C., Fong, A. M., La-Beck, N. M., Newman, S. E., Clarke-Pearson, D. L., Brewster, W. R., Van Le, L., Bae-Jump, V. L., Gehrig, P. A., Zamboni, W.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Pharmacoepidemiology of clinically relevant hypothyroidism and hypertension from sunitinib and sorafenib
Walko, C. M., Aubert, R. E., La-Beck, N. M., Hawk, G., Herrera, V., Kourlas, H., Epstein, R. S., McLeod, H. L.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
The evaluation of gender on the pharmacokinetics (PK) of pegylated liposomal anticancer agents
La-Beck, N. M., Wu, H., Infante, J. R., Jones, S. F., Burris, H. A., Keedy, V. L., Kodaira, H., Ikeda, S., Ramanathan, R. K., Zamboni, W.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Evaluation of the relationship between patient factors and the reduction in clearance of pegylated liposomal doxorubicin
La-Beck, N. M., Zamboni, B. A., Tzemach, D., Schmeeda, H., Sapir, R., Gabizon, A., Zamboni, W. C.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Technetium-99m sulfur colloid (TSC) as a phenotypic probe for the pharmacokinetics (PK) and pharmacodynamics (PD) of pegylated liposomal doxorubicin (PLD) in patients (pts) with recurrent epithelial ovarian cancer (EOC)
Walsh, M. D., Giovinazzo, H., Sheikh, A., Ivanovic, M., Whitlow, A. B., Newman, S. E., La-Beck, N. M., Kowalsky, R. J., Zamboni, B. A., Clarke-Pearson, D. L., Brewster, W. R., Van Le, L., Bae-Jump, V. L., Gehrig, P. A., Zamboni, W.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article